Table 1. Clinical characteristics of the Huntington's disease (HD) patients and the controls.
Controls (n = 18) | HD patients (n = 9) | |
Gender (male/female) | 7/11 | 5/4 |
Age (years) | 45.8±3.0 (26–64)# | 43.4±3.4 (25–57) |
Age at symptom onset (years) | 38.9±4.0 (15–53) | |
Body mass index | 23.4±0.8 | 21.0±1.1* |
Disease duration (years) | 4.9±1.0 (2–10) | |
Expanded CAG repeat No | 46.1±2.3 (41–62) | |
UHDRS | ||
Motor score | 32.2±7.4 (9–69) | |
Independence scale | 78.9±6.6 (40–100) | |
Functional capacity | 9.2±1.2 (3–13) |
Values are expressed as means ± SE (range; minimum–maximum).
UHDRS: The Unified Huntington's Disease Rating Scale. Scale ranges (normal to most severe) include motor score (0 to 124), independence score (100 to 10), and functional capacity (13 to 0).
#Three different groups from controls (9 in each group) were compared with 9 HD patients for prothrombin/Alb, Apo A-IV/Alb, and haptoglobin, respectively (The ages of the 3 groups were 41.7±4.3, 45.7±4.7, and 41.1±4.1).
*P = 0.09.